Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMC Markets Regulatory News (CMCX)

Share Price Information for CMC Markets (CMCX)

Share Price is delayed by 15 minutes
Get Live Data
463.50    8.50 (1.87%)
Bid:
460.00
Ask:
461.00
Spread: 1.00 (0.217%)
Market Cap: £1.26b
CMCX Live PriceLast checked at - London Stock Exchange

Intraday CMC Markets Share Chart

Evaluation of Managed Separation

15 Nov 2021 07:00

RNS Number : 3081S
CMC Markets Plc
15 November 2021
 

15 November 2021

CMC Markets Plc

 

Evaluation of Managed Separation of Leveraged and Non-leveraged Divisions

 

Following recent media speculation, the Board of CMC Markets Plc ("CMC" or the "Group"), a leading global provider of online trading and institutional ("B2B") platform technology solutions, confirms that it is in the very early stages of evaluating the merits of a managed separation of the leveraged and non-leveraged divisions of the Group ("the Review") in order to unlock shareholder value. The Review is consistent with the Board's continuous evaluation of strategic opportunities to maximise shareholder value.

On 10th June 2021 the Group announced with its full year 2021 results that as part of its strategy beyond leveraged trading (CFDs), it will be launching its new UK investment D2C and B2B platforms next year, offering investment products, physical shares, tax wrappers and third party funds.

 

Further to this, on 16th September 2021, the Group announced that the B2B white label deal with ANZ was ending and will be replaced by the acquisition of over 500,000 of ANZ's share investing clients with total assets in excess of £25 billion (AUD$ 45 billion), increasing combined Group client assets to approximately £40 billion, with approximately 1 million investing clients.

 

As a consequence of this acquisition, the growing size of investing clients and their assets, the launch of the new UK investment platform, and its growing B2B platform business, the Group boasts two strong underlying businesses, leveraged and non-leveraged. Both businesses have benefited from significant investment and each have strong growth prospects in sizeable markets with excellent competitive positions.

 

In this context, and in discussion with its advisers, the Board intends to undertake an exploratory review to consider the viability of a managed separation of the Group's non-leveraged and leveraged businesses in the interests of maximising shareholder value. As these discussions are exploratory at this stage, they may or may not lead to a managed separation of these businesses in due course.

 

The Board is expected to start its review before year end and complete it by June 2022 and will update the market in due course.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation ("MAR"). Upon the publication of this announcement via Regulatory Information Service ("RIS"), this inside information is considered to be in the public domain.

 

Enquiries

CMC Markets Plc

James Cartwright, Investor Relations investor.relations@cmcmarkets.com

Euan Marshall, Chief Financial Officer

 

Camarco +44 (0) 20 3757 4994

Geoffrey Pelham-Lane

Jennifer Renwick

 

Notes to Editors

 

CMC Markets Plc ("CMC"), whose shares are listed on the London Stock Exchange under the ticker CMCX (LEI: 213800VB75KAZBFH5U07), was established in 1989 and is now one of the world's leading online financial trading businesses. The Group serves retail and institutional clients through regulated offices and branches in 12 countries, with a significant presence in the UK, Australia, Germany and Singapore. CMC offers an award-winning, online and mobile trading platform, enabling clients to trade over 10,000 financial instruments across shares, indices, foreign currencies, commodities and treasuries through contracts for difference ("CFDs"), financial spread bets (in the UK and Ireland only) and, in Australia, access stockbroking services. More information is available at http://www.cmcmarkets.com/group/

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCKZMMMLDZGMZM
Date   Source Headline
6th Dec 202411:49 amRNSDirector/PDMR Shareholding
21st Nov 20247:05 amRNSDividend Declaration
21st Nov 20247:00 amRNSInterim Results
6th Nov 20243:29 pmRNSDirector/PDMR Shareholding
9th Oct 20249:42 amRNSDirector/PDMR Shareholding
9th Oct 20247:00 amRNSTrading Statement
9th Sep 20242:50 pmRNSDirector/PDMR Shareholding
3rd Sep 20244:13 pmRNSDirector/PDMR Shareholding
15th Aug 20243:07 pmRNSDirector/PDMR Shareholding
14th Aug 20244:15 pmRNSDirector/PDMR Shareholding
12th Aug 20249:25 amRNSDirector/PDMR Shareholding
6th Aug 20244:59 pmRNSDirector/PDMR Shareholding
25th Jul 20241:20 pmRNSResult of AGM
25th Jul 20247:00 amRNSQ1 2025 Trading Update
24th Jul 202410:42 amRNSDirector/PDMR Shareholding
10th Jul 202412:12 pmRNSDirector/PDMR Shareholding
8th Jul 20245:11 pmRNSDirector/PDMR Shareholding
24th Jun 20245:45 pmRNSNotice of AGM
20th Jun 20247:03 amRNSDividend Declaration
20th Jun 20247:03 amRNSDirectorate Change
20th Jun 20247:00 amRNSFinal results for the year ended 31 March 2024
7th Jun 202410:49 amRNSDirector/PDMR Shareholding
8th May 20243:10 pmRNSDirector/PDMR Shareholding
8th Apr 20243:12 pmRNSDirector/PDMR Shareholding
27th Mar 20247:00 amRNSFY 2024 Pre-Close Trading Update
6th Mar 20242:37 pmRNSDirector/PDMR Shareholding
23rd Feb 202410:03 amRNSNotification Under Listing Rule 9.6.14
6th Feb 20245:08 pmRNSDirector/PDMR Shareholding
5th Feb 20247:00 amRNSCost reduction and efficiency plans
30th Jan 20249:37 amRNSDirector/PDMR Shareholding
16th Jan 20244:57 pmRNSDirector/PDMR Shareholding
8th Jan 202410:43 amRNSDirector/PDMR Shareholding
8th Jan 20247:00 amRNSTrading Statement
6th Dec 20239:54 amRNSDirector/PDMR Shareholding
1st Dec 202312:54 pmRNSDirector/PDMR Shareholding
1st Dec 202312:49 pmRNSDirector/PDMR Shareholding
1st Dec 202312:41 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSInterim Results
7th Nov 20231:58 pmRNSDirector/PDMR Shareholding
6th Oct 20233:27 pmRNSDirector/PDMR Shareholding
25th Sep 202311:11 amRNSDirector/PDMR Shareholding
18th Sep 20232:48 pmRNSHolding(s) in Company
4th Sep 20237:00 amRNSAppointment of Chief Financial Officer
25th Aug 20237:00 amRNSTrading Statement
16th Aug 20231:52 pmRNSDirector/PDMR Shareholding
9th Aug 202312:13 pmRNSDirector/PDMR Shareholding
9th Aug 202312:11 pmRNSDirector/PDMR Shareholding
9th Aug 202312:10 pmRNSDirector/PDMR Shareholding
8th Aug 202310:00 amRNSDirector/PDMR Shareholding
27th Jul 20233:27 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.